Donepezil vs Upadacitinib

Donepezil vs Upadacitinib: Overview

This comparison examines the pharmacological differences between Donepezil and Upadacitinib.

Mechanism of Action

Donepezil: Reversible acetylcholinesterase inhibitor.

Upadacitinib: Selective JAK1 inhibitor reducing signaling from cytokines implicated in autoimmune diseases.

Pharmacokinetics

Half-life: Donepezil — 70 hours; Upadacitinib — 9-14 hours.

Chemical Properties

Molecular Formula: Donepezil — C24H29NO3; Upadacitinib — C17H19F3N6O.

Molecular Weight: Donepezil — 379.4920 g/mol; Upadacitinib — 380.3700 g/mol.

Type: Donepezil — Small molecule; Upadacitinib — Small molecule.